Skip to main content
Our Work

Speeding Therapeutics towards First-in-Human Trials for Nervous System Disorders: A Workshop

Completed

Topics

Current data suggests that drug development, from the start of a research program to FDA approval, can take anywhere from 10 to 17 years. However, there is a need to speed up this lengthy drug development process. On April 8-9, 2013, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop Accelerating Therapeutic Development for Nervous System Disorders towards First-in-Human Trials. This workshop explored opportunities to hasten the pathway from discovery to approval of the new therapeutics for nervous system disorders. Participants discussed the potential usefulness of new and emerging technologies in neuroscience research and potential challanges.

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.